Table 6. MDA-MB-231 versus SKBR3 Selectivity of the Best 2-Sulfonylpyrimidine/2-Thiopyrimidine Derivatives.
IC50 (μM) [95% CI] |
|||
---|---|---|---|
cpd | MDA-MB-231 | SKBR3 | cell selectivity ratio (IC50 SKBR3/IC50 MDA-MB-231) |
C9 | 48 [43–53] | ∼69 | ∼1.4 |
C9.12 | 17 [15–19] | 23 [22–26] | 1.4 |
C9.19 | 6 [6–7] | ∼13 | ∼2.2 |
C9.20 | ∼28 | ∼29 | ∼1.0 |
C9.22 | 4.2 [4.0–4.4] | ∼13 | ∼3.1 |
C9.24 | 105 [73–172] | >200 | >1.9 |
C9.25 | 180 [73–??] | >400 | >2.2 |
CB-839 | 0.038 [0.031–0.048] | >1 | >26 |